Contact Us | Log In
Search
Sensex: 33342.8 +236.00 Gold: Rs.29653.00
Nifty: 10283.6 +68.80 Silver: Rs.39847.00
Torrent Pharma Q2FY18: Muted Quarterly Show; Unichem Deal to Boost Domestic Volume - IndiaNotes.com
Torrent Pharma Q2FY18: Muted Quarterly Show; Unichem Deal to Boost Domestic Volume
Reliance Securities | Published: 14 Nov, 2017  | Source : IndiaNotes.com

Envisaging a healthy growth in India and Brazil businesses led by new launches and improvement in sale force productivity, we maintain our BUY recommendation and Target Price of Rs1,450, valuing the stock at 20x FY19E EPS of Rs 72.5.


Link to the PDF



About Reliance Securities

Reliance Securities, the broking arm of Reliance Capital, is one of the India’s leading retail broking houses, providing customers with access to equities, derivatives, currency, IPOs, mutual funds, bonds, and corporate FDs amongst others. The large array of financial offerings helps customers fulfilling their investment objectives on one platform. Focus on timely & error-free execution represents its core strength. Their best in class research offerings, high degree of compliance with stock exchange regulations, ethical business standards, & strong risk management capabilities; Reliance Securities positions itself amongst strong & innovative brands in the financial services space.


For more information please write in to editor@indianotes.com


Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.

 

logo
BSE : 1,258.15 -11.10
(-0.87%)
NSE : 1,263.05 -9.25
(-0.73%)
Read More